Viyash Scientific Limited has concluded a transformative fiscal year, reporting its strongest quarter in company history for Q4 FY26. Driven by successful business integration and merger synergies, the company achieved ₹9,200 million in revenue, representing a 19.1% year-on-year growth. Operating leverage improvements and disciplined cost controls have significantly bolstered margins, while a strategic focus on deleveraging the balance sheet has positioned the company for sustained growth in the upcoming fiscal year.
Financial Growth and Margin Expansion
The company delivered robust financial results for the quarter ended March 31, 2026. Quarterly revenue stood at ₹9,200 million, a 19.1% increase over the same period last year. For the full fiscal year 2026, revenue reached ₹34,203 million, reflecting 13.8% year-on-year growth. Profitability also saw a significant boost, with quarterly EBITDA rising 63.8% year-on-year to ₹2,001 million, achieving an EBITDA margin of 21.7%, a notable expansion of 590 basis points.
Strategic Synergy and Operational Highlights
Fiscal Year 2026 was marked by the successful unification of the company’s facilities and operations. Management highlighted that merger synergies are now reflecting in financial performance, leading to improved operating leverage. Key operational milestones for Q4 include the completion of 6 cost improvement projects, the validation of 6 new intermediate products, and the development of 6 new animal health products. Furthermore, the company successfully reduced its Net Debt to LTM EBITDA ratio to 0.2x, down from 1.0x in FY25.
Future Growth Outlook
As Viyash Scientific transitions into FY27, the focus remains on leveraging its integrated platform to drive long-term value. With a significantly deleveraged balance sheet, the company is actively evaluating inorganic growth opportunities to further expand its capabilities. The current product pipeline, which includes 19 new products, combined with increased asset utilization and agile pricing strategies, is expected to maintain the company’s resilience against global supply chain disruptions.
Source: BSE
